Macrocyclics opens offices in Asia

Source：Ringier Medical Release Date：2014-07-08 385

Medical Equipment

Expansion in in China, Japan and South Korea will allow better access to information and services

MACROCYCLICS, the Dallas, Texas-based leader in high performance chelating agent technologies for medicine, Inc. (an), has expanded in Asia with new offices located in China, Japan and South Korea. An office has also been launched in France, the AREVA Med company also said.

While the manufacture of customized chelating agents used in nuclear medicine and medical imaging remains based in Dallas, Asian and French customers will now have a local contact for placing orders and obtaining technical information about all products and services available from Macrocyclics, and the ability to communicate in their own language as well as in English.

To reach Macrocyclics in their new offices, please use the following:

Beijing, China

Mrs. Carrie SONG

+86 150 1146 1640

china@macrocyclics.com

Tokyo, Japan

Mr. Sebastien PAES

+81 90 2620 5448

japan@macrocyclics.com

Seoul, South Korea

Mrs. Hye-Young PARK

+82 2 551 0165